Author: Thomas DeFelice

Dilworth IP Partner Appointed to CURE’s Board of Directors

Dr. Anthony Sabatelli, Partner and Chair of Dilworth IP’s Biotech and Pharmaceutical IP practice group, has been appointed to serve on CURE’s Board of Directors. CURE (Connecticut United for Research Excellence) serves as the bioscience cluster for the state, and is a diverse community of small and large life and healthcare sciences companies, ranging in scope from therapeutics, to healthcare technology, to medical devices. Universities, government agencies, scientists, educators, mentors, students, entrepreneurs, business experts, service providers and investors further form the breadth of the network. Regarding his appointment, Dr. Sabatelli said that “I am honored to serve CURE in this capacity because it is an important advocate for the state’s bioscience community.”

Innovation: from Discovery to Application – Dilworth IP Attorneys to Present at ACS Fall Meeting in Boston

Dr. Anthony Sabatelli and Dr. Jonathan Schuchardt, both Partners at Dilworth IP, will be presenting at the 250th American Chemical Society National Meeting and Exposition in Boston this Thursday, August 20th. The theme of this year’s meeting is Innovation: from Discovery to Application and both presentations will be part of the ACS’s Chemistry and the Law (CHAL) Division’s slate of talks.